Epstein-Barr virus DNA load kinetics analysis in allogeneic hematopoietic stem cell transplant recipients: Is it of any clinical usefulness?-Reference-Cited by-同舟云学术

Epstein-Barr virus DNA load kinetics analysis in allogeneic hematopoietic stem cell transplant recipients: Is it of any clinical usefulness?

Published:2017-12 Issue: Volume:97 Page:26-32
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Solano Carlos,Mateo Eva María,Pérez Ariadna,Talaya Alberto,Terol María José,Albert Eliseo,Giménez Estela,Vinuesa Víctor,Piñana José Luis,Boluda Juan Carlos Hernández,Navarro David

Funder

Ministry of Economy and Competitiveness (MINECO, Spanish Government)

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference41 articles.

1. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation;Landgren;Blood,2009

2. Measuring Epstein Barr virus (EBV) load: the significance and application for each EBV-associated disease;Kimura;Rev. Med. Virol.,2008

3. EBV viral load detection in clinical virology;Gärtner;J. Clin. Virol.,2010

4. Using Epstein-Barr viral load assays to diagnose monitor, and prevent posttransplant lymphoproliferative disorder;Gulley;Clin. Microbiol. Rev.,2010

5. Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: sixth European conference on infections in leukemia (ECIL-6) guidelines;Styczynski;Haematologica,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epstein–Barr Virus Monitoring after an Allogeneic Hematopoietic Stem Cell Transplant: Review of the Recent Data and Current Practices in Canada;Current Oncology;2024-05-14

2. Pre-Emptive Use of Rituximab in Epstein–Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes;International Journal of Molecular Sciences;2023-11-07

3. Prolonged Epstein-Barr virus reactivation coincident with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation;Leukemia & Lymphoma;2021-11-16

4. Epstein–Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes;Current Opinion in Infectious Diseases;2021-09-16

5. Central Nervous System Involvement in Epstein–Barr Virus-Related Post-Transplant Lymphoproliferative Disorders after Allogeneic Hematopoietic Stem Cell Transplantation;Transplantation and Cellular Therapy;2021-03